Samsung Biologics Co.,Ltd. (207940.KS)
Samsung Biologics Co.,Ltd., commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
1,479,000.00-0.05%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-7.0%
The outlook
Samsung Biologics Co.,Ltd. currently reads as leaning bullish based on strong buy — 1.4 avg of 25 analysts, mixed vs its moving averages, 74% of the way from its 52-week low to high, avg target +34% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 25 analysts
Price trendMixed vs its moving averages
52-week range74% of the way from its 52-week low to high
Price targetAvg target +34% vs current price
Analyst price target
~12-month · 25 analysts1,975,520.00average target+33.6% vs now
Now 1,479,000.00
Low 1,600,000.00High 2,200,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$68.46T
52-wk high
1,987,000.00
52-wk low
0.00
50-day avg
1,376,760.00
200-day avg
1,614,968.10
Trailing P/E
—